News and Trends 14 Dec 2022
STORM Therapeutics closes $30M Series B financing
STORM Therapeutics Ltd., which is working on discovering and developing novel small molecule therapies targeting RNA modifying enzymes (RMEs) for oncology and other diseases, has successfully completed a $30 million…
